655 research outputs found
Becoming A/r/tographers whilst contesting rationalist discourses of work
No full textExtending critical perspectives which have problematized “work,” in this essay we
contest rationalist values of “work” through a/r/tography, noting that a/r/tography is
particularly suited to troubling the artificial divisions and correlative productivities
between art and research, teacher and student, teacher and researcher, and so forth.
We explore the notions of transmediation and pedagogical recognition to suggest
that if our educative systems, processes, and imaginations could more generatively
attend to students as creative beings, and if students could be invited to a fuller
activity in the world across multiple domains, then an increasing social tendency
to accept economic values as trumping all others might be redressed. We argue
that how adults value young people in the progress and process of their making art,
making knowledge, and making a life, comes to affect the ontology and epistemology
of work in all its social manifestations
Palliative Care: A Novel Solution to the Healthcare Crisis. Syracuse Seminar Series on Aging.
No full textPalliative care is specialized healthcare for anyone who is diagnosed with a serious and life-threatening illness, starting when they get the diagnosis, regardless of the prognosis. Although hospice is a form of palliative care, most palliative care is not end-of-life care or hospice, a common misperception that deters many people from using palliative care when they would benefit from it. Palliative care improves quality of care, reduces hospital costs, and helps clinicians address the needs and wants of patients and their families, which is why I refer to it as a 'novel' solution to the longstanding healthcare crisis.palliative care, hospice, patient autonomy, access to information, pain, distress, serious illness, cancer, depression, physical discomfort, medical education,
Supplemental Material - Spatiotemporal Patterns of Hospitalizations Among Older Adults With Co-Presence of Cancer and Dementia in US Counties: 2013–2018
No full textSupplemental Material for Spatiotemporal Patterns of Hospitalizations Among Older Adults With Co-presence of Cancer and Dementia in US Counties: 2013–2018 by Weixin Li, Lihua Li, Katherine A Ornstein, R. Sean Morrison and Bian Liu in Journal of Applied Gerontology</p
20190630__online_supp – Supplemental material for Economic Analysis of Hospital Palliative Care: Investigating Heterogeneity by Noncancer Diagnoses
No full textSupplemental material, 20190630__online_supp for Economic Analysis of Hospital Palliative Care: Investigating Heterogeneity by Noncancer Diagnoses by Peter May, Charles Normand, Egidio Del Fabbro, Robert L. Fine, R. Sean Morrison, Isabel Ottewill, Chessie Robinson and J. Brian Cassel in MDM Policy & Practice</p
of Geriatrics and Palliative Medicine, and Hermann Merkin Professor of Palliative Care at the Mount Sinai School of Medicine in New York. He is also President of the American Association of Hospice and Palliative
No full textDr. Morrison’s research focuses on decision making at the end of life, pain and symptom management in high-risk and medically underserved populations, and quality measures in palliative care. He has received numerous awards for his research in geriatrics and palliative care and has been named a Brookdale National Fellow, an Open Society Institute Project on Death in America Faculty Scholar, and an American Federation for Aging Research Paul Beeson Faculty Scholar. He is an active clinician who cares for healthy older adults and those with serious illness. Dr. Morrison received his MD from the University of Chicago Pritzker School of Medicine, completed residency training in Internal Medicin
sj-docx-2-pal-10.1177_08258597241231042 - Supplemental material for Place of Death for Adults Receiving Specialist Palliative Care in Their Last 3 Months of Life: Factors Associated With Preferred Place, Actual Place, and Place of Death Congruence
No full textSupplemental material, sj-docx-2-pal-10.1177_08258597241231042 for Place of Death for Adults Receiving Specialist Palliative Care in Their Last 3 Months of Life: Factors Associated With Preferred Place, Actual Place, and Place of Death Congruence by Samantha Smith, Aoife Brick, Bridget Johnston, Karen Ryan, Regina McQuillan, Sinead O’Hara, Peter May, Elsa Droog, Barbara Daveson, R. Sean Morrison, Irene J. Higginson and Charles Normand in Journal of Palliative Care</p
sj-docx-1-pal-10.1177_08258597241231042 - Supplemental material for Place of Death for Adults Receiving Specialist Palliative Care in Their Last 3 Months of Life: Factors Associated With Preferred Place, Actual Place, and Place of Death Congruence
No full textSupplemental material, sj-docx-1-pal-10.1177_08258597241231042 for Place of Death for Adults Receiving Specialist Palliative Care in Their Last 3 Months of Life: Factors Associated With Preferred Place, Actual Place, and Place of Death Congruence by Samantha Smith, Aoife Brick, Bridget Johnston, Karen Ryan, Regina McQuillan, Sinead O’Hara, Peter May, Elsa Droog, Barbara Daveson, R. Sean Morrison, Irene J. Higginson and Charles Normand in Journal of Palliative Care</p
Prospective cohort study of hospital inpatients with advanced cancer : cost analysis of a palliative care consultation team intervention
No full textTHESIS 10907The provision of care to people living and dying with serious chronic illness is a public health priority in most parts of the world. In a context of demographic change and shifting patterns of disease, the cost of care for this patient group is projected to grow substantially in the coming decades. Models of care that improve patient and family outcomes in a financially sustainable manner are urgently sought
Revised_PMJ-18-0419_Care_costs_and_quality_Suppl – Supplemental material for Drivers of care costs and quality in the last 3 months of life among older people receiving palliative care: A multinational mortality follow-back survey across England, Ireland and the United States
No full textSupplemental material, Revised_PMJ-18-0419_Care_costs_and_quality_Suppl for Drivers of care costs and quality in the last 3 months of life among older people receiving palliative care: A multinational mortality follow-back survey across England, Ireland and the United States by Deokhee Yi, Bridget M Johnston, Karen Ryan, Barbara A Daveson, Diane E Meier, Melinda Smith, Regina McQuillan, Lucy Selman, Steven Z Pantilat, Charles Normand, R Sean Morrison and Irene J Higginson in Palliative Medicine</p
Efficient tumour formation by single human melanoma cells
No full textA fundamental question in cancer biology is whether cells with tumorigenic potential are common or rare within human cancers. Studies on diverse cancers, including melanoma, have indicated that only rare human cancer cells ( 0.1 - 0.0001%) form tumours when transplanted into non- obese diabetic/ severe combined immunodeficiency ( NOD/ SCID) mice. However, the extent to which NOD/ SCID mice underestimate the frequency of tumorigenic human cancer cells has been uncertain. Here we show that modified xenotransplantation assay conditions, including the use of more highly immunocompromised NOD/ SCID interleukin- 2 receptor gamma chain null (Il2rg(-/-)) mice, can increase the detection of tumorigenic melanoma cells by several orders of magnitude. In limiting dilution assays, approximately 25% of unselected melanoma cells from 12 different patients, including cells from primary and metastatic melanomas obtained directly from patients, formed tumours under these more permissive conditions. In single- cell transplants, an average of 27% of unselected melanoma cells from four different patients formed tumours. Modifications to xenotransplantation assays can therefore dramatically increase the detectable frequency of tumorigenic cells, demonstrating that they are common in some human cancers.Howard Hughes Medical Institute ; Allen H. Blondy Research Fellowship ; Lewis and Lillian Becker ; University of Michigan Comprehensive Cancer Center ; National Institutes of Health [CA46592]; University of Michigan Flow Cytometry Core Facility ; N. McAnsh and the University of Michigan Cancer Centre Histology Core ; National Institute of Diabetes, Digestive, and Kidney Diseases [NIH5P60- DK20572]; Michigan Diabetes Research and Training Center ; Spanish Ministry of Education ; Marie Curie Outgoing International Fellowship from the European Commission ; Australian National Health and Medical Research Council ; Human Frontiers Science Program and Australia PostThis work was supported by the Howard Hughes Medical Institute and by the Allen H. Blondy Research Fellowship. The University of Michigan Melanoma Bank was supported by a gift from Lewis and Lillian Becker. Flow cytometry was partly supported by the University of Michigan Comprehensive Cancer Center grant from the National Institutes of Health CA46592. We thank: D. Adams, M. White and the University of Michigan Flow Cytometry Core Facility for support; N. McAnsh and the University of Michigan Cancer Centre Histology Core for histological studies; G. K. Smyth for assistance with statistics; and Z. Azizan for support with tissue collection. Antibody production was supported in part by the National Institute of Diabetes, Digestive, and Kidney Diseases, grant NIH5P60- DK20572 to the Michigan Diabetes Research and Training Center. Some antibodies were provided by Caltag or by eBioscience to screen for cancer stem- cell markers. Human primary melanocyte cultures were provided by M. Soengas. Human mesenchymal stem cells were provided by Z. Wang and P. Krebsbach. E. Q. was supported by the Spanish Ministry of Education and the Marie Curie Outgoing International Fellowship from the European Commission. M. S. was supported by the Australian National Health and Medical Research Council, the Human Frontiers Science Program and Australia Post.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/62970/1/nature07567.pd
- …
